NCT00514488View on ClinicalTrials.gov

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2004

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

STI571 (400 mg/day; or 800 mg/day)

Trial Locations (1)

Unknown

"Istituto di Ematologia e Oncologia Medica L. e A. Seràgnoli", Bologna

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Bologna

OTHER